Latest News for: domain (protein)

Edit

NLRP3 Protein Inhibitors Clinical Trials Analysis 2025: EMA, PDMA, FDA Approvals, Clinical Trials, Therapies, Medication, ...

GetNews 16 Apr 2025
... pipeline domain ... NOD-like receptor family pyrin domain-containing 3 (NLRP3) protein is a key component of the innate immune system, playing a crucial role in the activation of the inflammasome.
Edit

Influenza A Infections Market Across the 7MM Expected to Experience Significant Growth by 2032 | DelveInsight

GetNews 11 Apr 2025
dominating the market among the 7MM countries ... Current strategies focus on targeting highly conserved regions of hemagglutinin (HA), neuraminidase (NA), the M2 extracellular domain (M2e), and internal proteins of the influenza virus ... Visit the ... 1 ... 2 ... 3 ... 4.
Edit

Diabetes Pipeline Insights, Clinical Trials Report 2025: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, ...

GetNews 08 Apr 2025
Insulin efsitora alfa (LY3209590) is a once-weekly basal insulin, a fusion protein that combines a novel single-chain variant of insulin with a human IgG2 Fc domain.
Edit

Tharimmune Announces Positive Data with Novel Biparatopic PD-1/VEGF and Multispecific HER2/HER3 Biologics Leveraging Proprietary EpiClick(TM) Technology

ACCESSWIRE 07 Apr 2025
Inspired by bovine antibodies' unique "knob-and-stalk" structure, EpiClick uses engineered "knob" domains - small, precise binding units - that can "click" into recessed protein sites inaccessible to conventional antibodies.
Edit

Unstable Protein Variants Linked to Many Human Diseases

The Scientist 04 Apr 2025
Moving forward, Beltran plans to expand the study to include longer domains and possibly entire proteins and measure other properties such as protein-protein interactions and aggregations.
Edit

EGFR Non Small Cell Lung Cancer Pipeline 2025: Therapies Under Investigation, Clinical Trials Milestones, and ...

GetNews 04 Apr 2025
ICP-189, developed by InnoCare, is an allosteric inhibitor of Src Homology 2 domain containing protein tyrosine phosphatase (SHP2), while furmonertinib is a brain-penetrant, mutation-selective inhibitor of the epidermal growth factor receptor (EGFR).
Edit

Cotranslational membrane insertion of the voltage-sensitive K+ channel KvAP

PNAS 31 Mar 2025
Some proteins, such as voltage-sensitive channels, require their ...
  • 1
×